Abstract
Severe asthma is frequently associated with comorbidities. Nasal polyps (NP), in particular, indicate an eosinophilic phenotype and have been shown to predict an enhanced response to benralizumab in terms of asthma exacerbations and lung function. I
Original language | English |
---|---|
Article number | A1355 |
Number of pages | 1 |
Journal | American Journal of Respiratory and Critical Care Medicine |
Volume | 203 |
Early online date | 19 May 2021 |
DOIs | |
Publication status | Published - 2021 |
Event | ATS International Conference Committee: ATS 2021 - Virtual event Duration: 14 May 2021 → 19 May 2021 https://conference.thoracic.org/ |